StockpollyBeta
Get App
Delisting riskPopularity #3,841
SLXN · NASDAQ · Biotechnology

Silexion Therapeutics (SLXN)

Develops RNA-targeting treatment candidates for KRAS-mutated pancreatic cancer.

$0.4701
vs last close−0.07 (−13.60%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions0.07%3.6K shares
7 holders · as of Mar 31, 2026
Insiders1.65%91.5K shares
9 holders · as of Jun 8, 2026
Other98.28%5.47M shares
remainder

5.56M company shares as of Sep 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (5.56M in the company's Sep 22, 2026 report, 419.0K elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Ilan LevinInsiderdirector, 10 percent owner
0.82%45,697filed Jan 27, 2026
Ilan HadarInsiderdirector, officer: Chairman and CEO
0.30%16,547filed Jun 8, 2026
Hadar Mirit HorenshteinInsiderofficer: CFO and Secretary
0.23%12,515filed Jun 8, 2026
Mitchell ShirvanInsiderofficer: CSO and CDO
0.16%8,789filed Jun 8, 2026
Avner LushiInsiderdirector
0.05%2,540filed Feb 23, 2026
Shlomo NoyInsiderdirector
0.05%2,540filed Feb 25, 2026
Citadel Advisors LLCInstitution
0.04%20,926as of Mar 31, 2026
Two Sigma Securities, LLCInstitution
0.02%11,657as of Mar 31, 2026
Ruth AlonInsiderdirector
0.02%1,023filed Feb 23, 2026
Dror Yosef AbramovInsiderdirector
0.02%1,018filed Feb 23, 2026
Amnon PeledInsiderdirector
0.01%824filed Feb 23, 2026
Montag A & Associates IncInstitution
0.01%3,000as of Mar 31, 2026
UBS Group AGInstitution
0.00%517as of Mar 31, 2026
Pflug Koory, LLCInstitution
0.00%333as of Mar 31, 2026
Jones Financial Companies LLLPInstitution
0.00%26as of Mar 31, 2026
Sbi Securities Co., Ltd.Institution
0.00%20as of Mar 31, 2026
Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)Institution
—13.80% of class, as filed—filed Nov 20, 2024
Lincoln Alternative Strategies LLCStrategic
—6.18% of class, as filed—filed Sep 15, 2025
Moringa Sponsor, LPInstitution
—25.00% of class, as filed—filed Aug 19, 2026
Wildcat Capital Management, LLC1,2Strategic10 percent owner
0.01%756filed Aug 15, 2024
Ilan Shiloah1Insiderdirector
0.01%287filed Aug 15, 2024
  1. Last filed Aug 15, 2024; leaving the company requires no filing. Not in the bar.
  2. Reported at 1.30% on Jun 26, 2025, under the 5% line, so no further filing is required.

13F, as of Mar 31, 2026

7 holders · 36.5K shares · 1 new position · 2 increased · 2 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
Citadel Advisors LLC20.9K0.38%+8.7KMay 15, 2026
Two Sigma Securities, LLC11.7K0.21%+11.7KnewMay 15, 2026
Montag A & Associates Inc3.0K0.05%0Apr 29, 2026
UBS Group AG5170.01%−1.2KMay 5, 2026
Pflug Koory, LLC3330.01%0Apr 22, 2026
Jones Financial Companies LLLP260.00%0May 15, 2026
Sbi Securities Co., Ltd.200.00%−1.0KApr 28, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Moringa Sponsor, LPincl. Ilan Levin, Moringa Partners Ltd25.00%13DAug 19, 2026
Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)incl. Shlomo Noy, Avner Lushi13.80%13DNov 20, 2024
Lincoln Alternative Strategies LLC6.18%13GSep 15, 2025

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Mar 26, 2026
Mitchell Shirvanofficer: CSO and CDO
Sale22,818$1.3627,889

House and Senate disclosures

Not reported.